About Oleg Nodelman
Oleg Nodelman is a director and 10% owner at Aktis Oncology.
Oleg Nodelman reports to the SEC as a director, officer or major shareholder of 9 public companies, including Zymeworks (ZYME), Anaptysbio (ANAB) and Nuvation Bio (NUVB).
Oleg Nodelman first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name Oleg Nodelman in the role, so the role may have started earlier or lasted longer.
ZI
Zymeworks Inc.
Director and 10% owner
2025 · Public company (ZYME)
AI
Anaptysbio, Inc.
Director and 10% owner
2021 – 2025 · Public company (ANAB)
NI
Nuvation Bio Inc.
CEO and Chairman of the Board
2020 – 2023 · Public company (NUVB)
PI
Panacea Acquisition Corp. II
CEO and Chairman of the Board
2021 – 2023 · Public company (PANA)
PC
Prothena Corp. Public Ltd. Co.
Director and 10% owner
2019 · Public company (PRTA)
KI
Kindred Biosciences, Inc.
Director
2013 – 2014 · Public company (KIN)
GI
Genvec Inc.
10% owner
2013 – 2014 · Public company (GNVC)
AI
Avigen Inc.
Reporting person
2009 · Public company (AVGN)
Key Colleagues at Startups
The people Oleg Nodelman works with at each company, as listed on that company's latest Form D.
Aktis Oncology, Inc. · Form D, Oct 2, 2024
HK
Helen Kim
Director
SB
Shulamit Ron-Bigger
Executive officer
KH
Ken Herrmann
Director
LS
Lloyd Segal
Director
AL
Andrew Levin
Director
MR
Matthew Roden
CEO and director
TF
Todd Foley
Director